16 December 2022 - Cyralux is also the first and only targeted molecular imaging agent that illuminates ovarian cancer in ...
14 November 2022 - Building on its contributions to newborn screening globally, PerkinElmer’s latest FDA authorised assay enables the simultaneous ...
24 October 2022 - Invivoscribe is pleased to announce that they have filed a supplemental pre-market approval submission with the ...
27 September 2022 - Approval also marks the second NGS based companion diagnostic to identify RET fusion positive locally advanced or ...
27 September 2022 - Blue Earth Diagnostics today announced that the US FDA has accepted its filing for a new ...
22 September 2022 - Submission follows completion of first in class trial demonstrating significant improvements in A1c reduction with investigational therapy ...
21 September 2022 - Vueway injection is highly stable and shows the highest relaxivity among gadolinium-based contrast agents available for ...
21 September 2022 - FDA approval of Elucirem was granted after priority review, a designation assigned to applications for drugs ...
13 September 2022 - Company highlights growing nuclear medicine product portfolio and future opportunities in therapeutic radioisotopes. ...
12 August 2022 - This approval marks the Oncomine Dx Target Test’s eighth companion diagnostic therapy selection indication ...
11 August 2022 - Based on cancer biomarkers, the first-of-its-kind VENTANA MMR RxDx Panel helps identify solid tumour patients, including endometrial ...
8 August 2022 - Bot Image has developed an AI driven medical device CAD software to significantly improve the accuracy and ...
29 July 2022 - Today, the U.S. FDA is providing an update on its multi-pronged response to monkeypox in the United ...
27 July 2022 - Bracco Diagnostics today announced that the U.S. FDA granted import discretion of Iomeron (iomeprol) into the ...
12 July 2022 - Bludigo is the first and only indigotindisulfonate sodium injection, USP, drug product approved by the FDA. ...